Brief: ProQR Therapeutics Provides Update On Ophthalmic Assets
Sept 27 (Reuters) - ProQR Therapeutics NV PRQR.O :
* PROQR THERAPEUTICS PROVIDES UPDATE ON OPHTHALMIC ASSETS
* PROQR THERAPEUTICS NV - AGREEMENT TO DIVEST COMPANY'S
LATE-STAGE
OPHTHALMIC ASSETS TO LABORATOIRES THÉA S.A.S. (THÉA) HAS BEEN
TERMINATED
Source text for Eikon: ID:nGNX6MmYs5
Further company coverage: PRQR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ProQR Therapeutics NV
See all newsProQR Therapeutics NV reports results for the quarter ended June 30 - Earnings Summary
ProQR Q2 revenue more than doubles
Brief: ProQR Therapeutics Q2 EPS EUR -0.08
ProQR Therapeutics NV expected to post a loss of 11 cents a share - Earnings Preview
ProQR Therapeutics NV expected to post a loss of 11 cents a share - Earnings Preview